{
  "denotations": [
    {
      "id": "T2",
      "obj": "Gene_or_protein",
      "span": {
        "begin": 14,
        "end": 18
      }
    },
    {
      "id": "T3",
      "obj": "Chemical",
      "span": {
        "begin": 83,
        "end": 92
      }
    },
    {
      "id": "T5",
      "obj": "Chemical",
      "span": {
        "begin": 97,
        "end": 109
      }
    },
    {
      "id": "T6",
      "obj": "Chemical",
      "span": {
        "begin": 83,
        "end": 109
      }
    },
    {
      "id": "T8",
      "obj": "Disease",
      "span": {
        "begin": 14,
        "end": 32
      }
    }
  ],
  "sourcedb": "PubMed",
  "sourceid": "16043828_13",
  "text": "Patients with KRAS -mutant NSCLC showed poorer clinical outcomes when treated with erlotinib and chemotherapy ."
}
